Uterine Leiomyoma in Kinshasa, the Capital of the Democratic Republic of Congo by P, Ingala et al.
  
68 
 
 American Scientific Research Journal for Engineering, Technology,  and Sciences  (ASRJETS) 
ISSN (Print) 2313-4410, ISSN (Online) 2313-4402 
© Global Society of Scientific Research and Researchers  
http://asrjetsjournal.org/  
 
Uterine Leiomyoma in Kinshasa, the Capital of the 
Democratic Republic of Congo 
Ingala Pa*, Lepira Fb, Muhindo Sc, Mputu Ld 
a,c,dDepartment of Obstetrics and Gynecology, University of Kinshasa Hospital, Kinshasa, 00243, Democratic 
Republic of Congo 
bDepartment of Internal Medicine, University of Kinshasa, Kinshasa, 00243, Democratic Republic of Congo 
 
Abstract 
The aim of the present study was to determine the particularities of Uterine Leiomyomas among Congolese in 
Kinshasa the capital of the Democratic Republic of Congo (DRC) in the present conditions of medical practices. 
A sample of 644 patients with uterine leiomyoma were selected from 6440 cases of uterine leiomyoma among 
30395 patients treated in gynecology units of three medical institutions of Kinshasa (University hospital of 
Kinshasa, Saint joseph hospital and Edith medical center) from January Ist ,2003 to December 31,2012. The 
study is a descriptive one. The following variables were taken account: medical history [age, age at menarche, 
parity, education, civil state, history of UL, symptoms and body mass index (BMI)]; lifestyle (smoking, alcohol 
intake); ultrasounds characteristics; hysteroslpingographies characteristics, treatment, and direct cost of 
treatment. Statistical analysis were performed using Excel 12.0 software. Demographic, clinical, ultrasound, 
hysterosalpingography and treatment data were evaluated using descriptive statistics: mean, standard deviation 
(SD), and percentage (%) as appropriate. The frequency of uterine leiomyoma was 21, 18%. That one concern 
mainly patients at 35 years old or more [49, 6% (35-44years), ≥45years (20, 6%)], singles (70, 4%), null parous 
(59,4%), having a high level of study (university: 54, 6%), history of UL (56, 7%), and alcohol intake (75, 5%). 
Hemorrhage (33, 2%) and pelvic pain (31, 6%) are the most frequent expression of those tumors. The most of 
those patients have excess weight (43, 1%) or obesity (46, 5%). The majority of uterine leiomyoma was 
corporeal (82, 9%) intramuscular (42, 4%) and their number didn’t overtake five by patient (70, 8%) in majority 
of cases. Majoration of the uterine cavity (46, 5%) and Fallopian tubes obstructions (30, 6%) are the most 
frequent abnormalities in hysterosalpingography. Myomectomy is the main treatment (65, 2%). The mean of 
direct cost were 803$ USA and 884$ USA for myomectomy and hysterectomy respectively. 
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1. Introduction 
The uterine leiomyoma (UL) is the most frequent genital tumor to women in reproductive age [1, 2, 3]. He is 
more frequent in black than white [4, 5, 6] and represents an important public health problem according to his 
incidence, prevalence, morbidity and cost of his management [7, 8].  
In the Democratic Republic of Congo (DRC) the characteristics of UL have been explored many years ago when 
ultrasound was not used commonly as one of diagnosis methods [9, 10].  
The objective of this paper is to evaluate the particularities of UL in the DRC regarding the present conditions of 
medical practices. 
2. Materials and Methods 
The study protocol was approved by the Ethical Committee of Kinshasa School of Public Health.  University of 
Kinshasa (ESP/CE/028/2013). 
6440 patients with UL have been collected in three medical institutions (University of Kinshasa hospital, Saint 
Joseph hospital and Edith medical center) of Kinshasa the capital of the DRC among 30395 patients who have 
been treated in the gynecology units from January 01, 2003 to December 31, 2012. A sample of 644 patients as 
been selected by random from those patients for the study. 
The study is a descriptive one. Her objective was to determine the actuals particularities of UL among 
Congolese women in Kinshasa.   
The following variables were taken account: medical history [age, age at menarche, parity, education, civil state, 
history of UL, symptoms and body mass index (BMI)]; lifestyle (smoking, alcohol intake); ultrasounds 
characteristics; hysterosalpingographies characteristics, treatment, and direct cost of treatment. 
Statistical analyses were performed using Excel 12.0 software. Demographic, clinical, ultrasound, 
hysterosalpingography and treatment data were evaluated using descriptive statistics: mean, standard deviation 
(SD), and percentage (%) as appropriate.  
3. Results 
Table I:  Frequency of uterine leiomyoma 
F = 6440 / 30394 .100 = 21, 18 % 
The table below show that the majority of patients have 35 years old or more [49, 6% (35-44years), ≥45years 
(20, 6%)], have had their menarche at 12 year or late (71, 8%), have none parity (null parous) (59,4%) or more 
(multiparous) (40,6%), have reached university (54, 6%) and are single (70, 4%). History of UL (56, 7%), and 
alcohol intake are the main characteristics of their medical history. 
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Hemorrhage (33, 2%) and pelvic pain (31, 6%) are the most frequent expression their tumor. The most of those 
patients have excess weight (43, 1%) or obesity (46, 5%).  
Table II:  Demographic, and clinical characteristics of patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From the table III the majority of uterine leiomyoma was corporeal (82, 9%), intramuscular (42, 4%) and their 
number didn’t overtake five by patient in the most of cases (70, 8%). 
 
VARIABLES n % 
 
   
Age (years) 
≤ 24 
25-34 
35-44 
≥45 
                                                        
10 
182 
320 
132 
 
1,5 
28,2  
49,6 
20,4  
Age at menarche (years) 
<12 
≥12 
                                             
182                                              
462 
 
28,2 
 71,8 
Parity 
0 
≥1 
                                                      
262 
382 
 
59,4 
 40,6 
Education 
Primary or less 
Secondary 
University 
 
146 
146 
352 
 
22,6  
 22,6 
 54,6 
Civil State 
Married 
Single 
 
191 
453 
 
29,6 
 70,4 
UL History 
Not 
Yes 
 
278 
366 
 
43,1 
 56,9 
Alcohol Intake 
Not 
Yes 
 
158 
486 
 
24,5 
 75,5 
Smoking 
Not 
Yes 
 
616 
28  
 
95,6  
4,4 
Symptoms 
Hemorrhage 
Pelvic Pain 
Infertility 
Others 
 
214 
 110  
204 
96 
 
33,2 
 17,0 
 31,6  
14,9 
BMI 
Normal 
Excess Weight 
Obesity 
 
66  
278 
 300 
 
10,2  
43,1 
 46,5 
   
American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS) (2017) Volume 38, No  2, pp 68-76 
71 
 
Table III: Ultrasounds characteristics of uterine leiomyomas 
Ultrasounds characteristics N % 
 
   
Localisation/ uterine subdivisions 
Corporeal 
Isthme 
Cervix 
 
 
534 
84 
26 
 
 
82,9 
 13,0 
 4,0 
Localisation/thickness 
Sub sessorial 
Intra mural 
Sub  mucosal 
Intra cavity 
 
100 
274 
192 
78 
 
15,5 
 42,4  
29,8 
 12,1 
Number 
≤5 
≥6-≤10 
≥11 
 
456 
102 
66 
 
70,8 
15,8  
 10,2 
   
Table IV: Hysterosalpingographies characteristics of uterine leiomyomas 
Hystersalpingographies 
characteristics 
N % 
 
             
      uterines images 
            normal 
            majoration of cavity 
            two cavities 
            synechies 
 
 
 
332 
300 
4 
8 
 
 
51,5  
46,5 
0,6  
1,2 
      tubes abnormalities 
            normal 
            obstruction 
            hydrosalpinx 
            phimosis 
                
 
408 
196 
26 
14 
 
 
63,3  
30,4 
4,0  
2,1 
The table IV show that majoration of the uterine cavity (46, 5%) and Fallopians tubes obstructions (30, 6%) are 
the more frequent  hysterosalpingographies abnormalities of uterine leiomyoma observed among patients in that 
study. 
Table V: Treatment 
Treatement N 
 
% 
   
                    medical 52 
 
8,0 
Myomectomy 
 
Hysterectomy 
                420 
 
172 
 
65,2 
 
26,7 
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The table V shows that myomectomy is the main treatment of UL (65, 2%). 
Table VI: Direct cost of treatment 
Medical institution 
 
Direct cost of myomectomy Direct cost of hystercetomy 
   
                  university hospital 
 
750$ usa 850$ usa 
Saint joseph hospital 
 
360$ usa 452$ usa 
Edith medical center 
 
1300$ usa 1350$ usa 
 
Mean 
 
803$usa 
 
884$usa 
   
 
The table VI show that the mean of direct cost of uterine leiomyoma are 803$ USA for myomectomy and 884$ 
USA for hysterectomy. 
4. Discussion  
 The present study shows that the frequency of UL is 21, 18%.  Althout that high level that result is comparable 
to those others  much Africans countries [11, 12].  On contrary of Africans countries the frequencies of UL in 
Europeans countries are less [13, 14]. Those observations support the opinion which consider that UL is the 
tumor of black women. The most of patients with UL have 35 years old or more. That result join the fact of 
advanced age and increasing age are two parameters which are always correlated with the rising of UL 
frequency. For explaining that phenomenon Rongieres & al [15], and Adama & al [16] think that by growing up, 
UL become symptomatics toward 40 years old and their diagnosis easiest. Majority of patients are nullparous 
(59,4%).  That result is an argument which support the fact of a reverse relation exists between increasing of 
parity and occurring of UL. For many authors that relation can be understood by hormonal and no hormonal 
change of deliveries. Among others the reduction of number of menses cycles, the regression of the level of 
estrogen and progesterone, and the increasing of sex binding globulin (SBG) [17, 18]. The presence of history of 
UL to much patients suggest the rule of heredity in the pathogenesis of UL. Alcohol intake, excess weight and 
obesity are others factors which are more found to patients in that study. Those results join many others results 
[19, 20] and can be explained by tumor genesis action of acetaldehyde providering from the metabolism of 
ethanol [21] and the contribution of lipid metabolism in the production of estrogen [22]. Hemorrhage and pelvic 
pain as the main expression of UL is not an exception for the study [23, 24]. The most frequent localization of 
Uterines leiomyomas was the corporeal one (82, 9%) as for Algeria women [25]. Fallopian tubes obstructions 
appear as the main abnormality of UL in hysterosalpingography. That result join others studies which 
demonstrated that fallopian obstructions is the commonest pathology found on HSG in women presenting 
infertility in Kinshasa (DRC) and Kampala (UGANDA) [26, 27].  
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Even if hysterectomy is the final treatment of UL [28, 29], the main surgical treatment is myomectomy in the 
present study. We think that that result can be understood according to the high need of maternity which 
characterize African area.   
The mean of direct cost of UL are 8O3$ USA and 884$ USA for myomectomy and hysterectomy respectively. 
Cravello & al [30], in France estimated direct cost to 4600FF for surgical hysteroscopy and to 7900 FF for 
vaginal hysterectomy.   Soliman & al. [31] estimated between 11.717 and 25.023 $ USA all expenses of UL 
management by patient in USA.  Cardoso & al. [32] evaluated expenses of UL between 5, 9-34, 4 billion $ USA 
by year in USA. The comparison of those cost evaluations suggest that the treatment of UL is less expensive in 
our area. But by taking account of level of life of the population, UL stay also an important problem of public 
health in DRC according to the cost of treatment.  
5. Conclusion 
 The present study show that the frequency of UL is 21, 18%.  The patients concerned are essentially those one 
of 35 years old and more, null parous, singles having a high level of education, a history of UL, alcohol intake 
and body mass index over than the normal ranch.  The majority of uterine leiomyoma are corporeal, 
intramuscular and their number didn’t overtake five by patient in majority of cases. Majoration of the uterine 
cavity and Fallopian tubes obstructions are the most frequent abnormalities in hysterosalpingography.  
Hemorrhage and pelvic pain are the most frequent expression of those tumors. Myomectomy is the main 
surgical treatment.  The direct cost is important for a third world country as DRC: 803$ USA and 884$USA for 
hysterectomy respectively. 
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